Skip to main content
ContextVision AB logo

ContextVision AB — Investor Relations & Filings

Ticker · CONTX ISIN · SE0014731154 LEI · 549300DGJB24U1VKHC98 OL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 267 across all filing types
Latest filing 2020-08-13 Interim / Quarterly Rep…
Country SE Sweden
Listing OL CONTX

About ContextVision AB

https://www.contextvision.se/

ContextVision is a medical technology software company specializing in image analysis and artificial intelligence. As a global market leader in image enhancement, it provides advanced software solutions to Original Equipment Manufacturers (OEMs) of medical imaging systems. The company's technology enhances image quality for modalities such as ultrasound, X-ray, and MRI, enabling faster and more reliable clinical diagnoses. Its versatile post-processing software is customized for each system to ensure optimal performance and is installed in over 400,000 systems globally. ContextVision is expanding its offerings with a modular ultrasound platform and is actively involved in developing diagnostic tools for digital pathology and liver disease.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for the second quarter of 2020 for ContextVision AB. It contains detailed financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business performance, risks, and accounting principles. It is clearly an interim financial report rather than a mere announcement or summary, as it provides substantive financial data and analysis for the period ending June 30, 2020. Q2 2020
2020-08-13 English
ContextVision Extraordinary General Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document reports the specific outcomes and voting results of an Extraordinary General Meeting (EGM) held by ContextVision, including the approval of board proposals regarding articles of association and a share split. Since it details the results of a shareholder meeting, it falls under the category of Declaration of Voting Results.
2020-08-05 English
ContextVision lanserar första CE-märkta digitala patologiprodukten
Regulatory Filings Classification · 1% confidence The document is a press release announcing that ContextVision has received CE-mark status for its new product, INIFY Prostate Screening. It describes the product's features, quotes the CEO, and provides company background. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a simple report publication announcement. As it is a general corporate announcement regarding product development and regulatory approval, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2020-06-29 Swedish
ContextVision lanserer sitt første digitale patologiprodukt med CE-merking
Regulatory Filings Classification · 1% confidence The document is a press release issued by ContextVision announcing the CE-marking and clinical availability of their new product, 'INIFY Prostate Screening'. It includes quotes from the CEO and a medical professional, describes the product's function, and concludes with a standard regulatory disclosure statement required by the EU Market Abuse Regulation and the Norwegian Securities Trading Act. Since this is a corporate announcement regarding product development and regulatory approval rather than a financial report, audit, or shareholder meeting material, it falls under the 'Regulatory Filings' category as a general corporate announcement.
2020-06-29 Norwegian
ContextVision announces first CE marked digital pathology product
Regulatory Filings Classification · 1% confidence The document is a press release announcing that ContextVision has received CE mark status for its new digital pathology product, INIFY Prostate Screening. It describes the product's features, market potential, and quotes from the CEO and a pathologist. It does not fit into financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general corporate announcement regarding product development and regulatory approval, it falls under the 'Regulatory Filings' (RNS) category as a catch-all for miscellaneous corporate news.
2020-06-29 English
ContextVision – Kallelse till extra bolagsstämma 2020
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice ('Kallelse') for an Extraordinary General Meeting (EGM) of ContextVision AB. It includes the agenda, proposals for a new articles of association and a stock split, and registration instructions for shareholders. This type of document is classified as Proxy Solicitation & Information Statement (PSI) as it provides the necessary information for shareholders to participate and vote in the upcoming meeting.
2020-06-24 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.